FDA Approved: COZAAR — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Cozaar (losartan)

Snippet

SUPPL AP for COZAAR (LOSARTAN POTASSIUM)